National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Apixaban (Eliquis®) for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

Rapid Review

Commenced Completed Outcome
07/12/2012 21/12/2012 Full Pharmacoeconomic Assessment Recommended

Pharmacoeconomic Evaluation

Commenced Completed Outcome
05/04/2013  31/05/2013 Reimbursement Recommended

Summary of NCPE appraisal (link